We are live on ! Find out more
DTIL icon

Precision BioSciences

55 hedge funds and large institutions have $14.7M invested in Precision BioSciences in 2024 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 18 increasing their positions, 8 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

125% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 8

40% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 10

8% more funds holding

Funds holding: 5155 (+4)

4.61% more ownership

Funds ownership: 45.97%50.58% (+4.6%)

51% less capital invested

Capital invested by funds: $29.8M → $14.7M (-$15.1M)

Holders
55
Holders Change
+4
Holders Change %
+7.84%
% of All Funds
0.72%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
14
Increased
18
Reduced
8
Closed
10
Calls
Puts
Net Calls
Net Calls Change

DTIL Hedge Fund Activity: Q4 2024 in Review

55 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Precision BioSciences (DTIL) for Q4 2024, worth a combined $14.7M — down 51% from $29.8M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new DTIL positions and 10 closed out — a net gain of 4 holders — while 18 added to existing stakes and 8 trimmed.

The largest buyer was Lynx1 Capital Management, opening a new position worth an estimated $5.59M. The largest seller was Janus Henderson Group, exiting entirely with an estimated $6.32M sold.

  • 55 institutional investors held Precision BioSciences (DTIL) as of Q4 2024, up from 51 in Q3 2024.
  • Funds reported $14.7M of Precision BioSciences stock for Q4 2024, down 51% quarter-over-quarter.
  • 14 funds opened new Precision BioSciences positions in Q4 2024 and 10 closed out, a net change of +4 holders.
  • The largest Precision BioSciences buyer in Q4 2024 was Lynx1 Capital Management, an estimated $5.59M added.
  • The largest Precision BioSciences seller in Q4 2024 was Janus Henderson Group, an estimated $6.32M sold.

Based on aggregated 13F filings for Q4 2024.